छोड़कर सामग्री पर जाएँ

Otsuka#39;s drug for Alzheimer#39;s disease agitation fails in late stage study

The treatment, AVP-786, failed to achieve statistically significant difference on the primary trial goal testing the efficacy of the candidates, compared to placebo.

Read More

​ The treatment, AVP-786, failed to achieve statistically significant difference on the primary trial goal testing the efficacy of the candidates, compared to placebo. The treatment, AVP-786, failed to achieve statistically significant difference on the primary trial goal testing the efficacy of the candidates, compared to placebo.  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी